BCMA was expressed in several hematologic malignancies, including multiple myeloma (MM), chronic lymphocytic leukemia, acute B-lymphoblastic leukemia, non-Hodgkin lymphoma (NHL), and Hodgkin lymphoma. This evidence concerns the gene TNFRSF17 and precursor B-cell acute lymphoblastic leukemia.